APICES SOLUCIONES S.L
My visitor profile
APICES SOLUCIONES S.L
Description of your activity
-
APICES is a midsize Full-Service Clinical CRO. We have assisted a large number of sponsors to structure, manage and execute over 300 clinical trials, in the field of pharmaceuticals, medical devices and IVDs.
We are covering phase 1 to phase 4 studies in Europe, and globally.
APICES has built more than 50% of its experience in Oncology.
More information
-
Created in 2009, founded by a group of highly qualified people with a vast experience in CROs and pharmaceutical companies, APICES is a company with Spanish identity and international vocation.
APICES is not only a CRO, but a Company giving an added value to customer in study design, clinical development planning and successful regulatory timelines to achieve customers milestones.
We are focused on our customer`s needs and their success, we adapt our team and resources to the customers needs and goals in local or international studies.
Most of our key employees have more than 20 years experience in Clinical Research field. APICES is a dynamic team specialized in different fields which altogether provide a real and updated vision of clinical research world and new scientific developments.
We offer to Sponsors clinical research services to improve the quality of investigational products development optimizing the processes and activities of clinical research and market access.
APICES delivers simplification of complex processes of clinical projects. We apply a full range of tools from field-tested technologies and with our experience and resources we are able to manage programs of any size in the most efficient way.
Mature Company
Christian SROKA
Business Development Manager
Main sector
- Professional Services & Consulting
Address
- Country : SPAIN
- City : Pinto, Madrid
- Zip Code : 28320
Participation objectives
Partnering objectives
- Network development
Description of my participation objective
- APICES is interested in meeting with potential biotech and pharma partners to discuss how we can support them in their Clinical Development in oncology.